Skip to Content
Merck
  • Dose reduction in computed tomography: the effect of eye and testicle shielding on radiation dose measured in patients with beryllium oxide-based optically stimulated luminescence dosimetry.

Dose reduction in computed tomography: the effect of eye and testicle shielding on radiation dose measured in patients with beryllium oxide-based optically stimulated luminescence dosimetry.

European radiology (2008-12-17)
Henrik Grobe, Marian Sommer, Arne Koch, Volker Hietschold, Jürgen Henniger, Nasreddin Abolmaali
ABSTRACT

The aim of this study was to assess the effect of eye and testicle shielding on radiation dose to the lens and the testes of patients undergoing CT examinations. Fifty-one male patients underwent CT twice with identical protocols initially without, the second time with protective garments. Doses to the testes and the lenses were recorded with beryllium oxide-based dosimeters. The dose to the testes and lenses from CT exposure was reduced by 96.2% +/- 1.7% and 28.2% +/- 18.5%, when testicle and eye shielding was used, respectively. The effect of the eye shielding on the eye lens dose was found to depend on the x-ray tube position when the eye is primarily exposed during the scan. The maximum eye lens dose reduction achieved was found to be 43.2% +/- 6.5% corresponding to the anterior position of the tube. A significant correlation between the patient's body mass index and dose exposure could not be found. Eye and testicle shields, apart from being inexpensive and easy to use, were proven to be effective in reducing eye lens and testicle radiation dose burden from CT exposures.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Beryllium oxide, 99.98% trace metals basis